Real World Experience
RA Video Resources
Prof. Ernest Choy's lecture on understanding the clinical significance of JAK selectivity in RA
Explore more
Dosing in RA
PP-XEL-GBR-3246. October 2021
Request an eRep
You can use the email below to contact a product representative and learn more about XELJANZ
[email protected]
XELJANZ Risk Minimisation Programme (RMP) materials, including a Patient Alert Card, Prescriber Checklists and a Prescriber Brochure are available from Patients treated with XELJANZ should be given the Patient Alert Card.

© 2021 Pfizer Pte Ltd. All rights reserved.

The information provided in this site is intended only for Healthcare Professionals in Singapore. The products discussed herein may have different product labelling in different countries. Pfizer Pte Ltd, Singapore is a subsidiary of Pfizer Inc, a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.